These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1725520)

  • 1. Relaxometry of dextran and albumin labeled with Gd-chelates.
    Niemi P; Reisto T; Kormano M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S48-9; discussion S60-4. PubMed ID: 1725520
    [No Abstract]   [Full Text] [Related]  

  • 2. Paramagnetic dextrans as magnetic resonance contrast agents.
    Meyer D; Schaefer M; Bouillot A; Beauté S; Chambon C
    Invest Radiol; 1991 Nov; 26 Suppl 1():S50-2; discussion S60-4. PubMed ID: 1725521
    [No Abstract]   [Full Text] [Related]  

  • 3. Multimodal contrast agents for in vivo neuroanatomical analysis of monosynaptic connections.
    Gambino G; Engelmann J; Tei L; Botta M; Logothetis NK; Mamedov I
    Biomaterials; 2013 Sep; 34(29):7135-42. PubMed ID: 23790308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response.
    Kanda T; Matsuda M; Toyoda K; Furui S
    Radiology; 2015 Aug; 276(2):616. PubMed ID: 26783575
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles.
    McDonald MA; Watkin KL
    Acad Radiol; 2006 Apr; 13(4):421-7. PubMed ID: 16554221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting and measuring free gadolinium in nanoparticles for MRI imaging.
    Clogston JD; Patri AK
    Methods Mol Biol; 2011; 697():101-8. PubMed ID: 21116958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
    Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
    J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple method for quantification of gadolinium magnetic resonance imaging contrast agents using ESR spectroscopy.
    Takeshita K; Kinoshita S; Okazaki S
    Chem Pharm Bull (Tokyo); 2012; 60(1):31-6. PubMed ID: 22223372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin.
    Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P
    Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.
    Telgmann L; Sperling M; Karst U
    Anal Chim Acta; 2013 Feb; 764():1-16. PubMed ID: 23374209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging.
    Laurent S; Vander Elst L; Galaup C; Leygue N; Boutry S; Picard C; Muller RN
    Contrast Media Mol Imaging; 2014; 9(4):300-12. PubMed ID: 24706614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging.
    Thompson MK; Misselwitz B; Tso LS; Doble DM; Schmitt-Willich H; Raymond KN
    J Med Chem; 2005 Jun; 48(11):3874-7. PubMed ID: 15916439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the tumour extracellular matrix by in vivo Fast Field Cycling relaxometry after the administration of a Gadolinium-based MRI contrast agent.
    Baroni S; Ruggiero MR; Aime S; Geninatti Crich S
    Magn Reson Chem; 2019 Aug; 57(10):845-851. PubMed ID: 30675933
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals.
    Baxter AB; Melnikoff S; Stites DP; Brasch RC
    Invest Radiol; 1991 Dec; 26(12):1035-40. PubMed ID: 1722486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to determine free Gd and free ligand in solution of Gd chelates. A technical note.
    Barge A; Cravotto G; Gianolio E; Fedeli F
    Contrast Media Mol Imaging; 2006; 1(5):184-8. PubMed ID: 17193695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of arsenazo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agent.
    Nagaraja TN; Croxen RL; Panda S; Knight RA; Keenan KA; Brown SL; Fenstermacher JD; Ewing JR
    J Neurosci Methods; 2006 Oct; 157(2):238-45. PubMed ID: 16769125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hepatobiliary gadolinium chelates for magnetic resonance imaging.
    Runge VM; Wells JW
    Acad Radiol; 1996 Aug; 3 Suppl 2():S455-7. PubMed ID: 8796628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.